Evaluation of the Erosive Effect of Chewing Aspocid versus its Soluble Form on Micro Hardness of Primary Teeth Enamel in Heart Disease Children. (In Vitro -Study)

Gehan G Allam,

doi:10.19070/2377-8075-19000134

Abstract

Evaluation of the Erosive Effect of Chewing Aspocid versus its Soluble Form on Micro Hardness of Primary Teeth Enamel in Heart Disease Children. (In Vitro -Study)

Highlights

Heart disease is one of the most common developmental abnormalities among children, occurring in approximately 8 to 10 in 1,000 births
Aspocid 75 mg chewing tablets is the usual drug used in children with heart disease, this acidic medicine is available in Egyptian markets and accessible by the public
Children with heart diseases take aspocid in chewable tablets which comes in direct contact with their teeth especially occlusal surfaces and that increase their susceptibility to dental erosion, usual doses are 75 - 100 mg/kg/day divided on 4 doses for 2 - 6 weeks to treat inflammation in children with rheumatic heart disease (RHD) and 5 mg/kg/day in single dose daily for life long to act as antiplatelet in children with congenital heart disease (CHD) [2]

Summary

Introduction

Heart disease is one of the most common developmental abnormalities among children, occurring in approximately 8 to 10 in 1,000 births. In addition that congenital heart disease (CHD)was accused to cause alteration in the structure of enamel and dentin of deciduous incisors, and significantly decrease in mineral content which increase susceptibility to erosion [3, 4]. Aspocid 75 mg chewing tablets (pH = 3) is the usual drug used in children with heart disease, this acidic medicine is available in Egyptian markets and accessible by the public. This may lead to increase their susceptibility to dental erosion. Conclusion: Aspocid caused reduction in enamel surface micro hardness in both groups

Objectives

Methods

Conclusion